Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)

Key facts

Sponsor

Dana-Farber Cancer Institute

Principal Investigator

Robert I. Haddad, MD, MD

Dana-Farber Cancer Institute

Intervention

carboplatin(drug)

Enrollment

145 enrolled

Eligibility

18 years · All sexes

Timeline

2004 – 2012

Study locations (15)

• Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
• CCOP - Colorado Cancer Research Program, Denver, Colorado, United States
• Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus, Boca Raton, Florida, United States
• Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
• Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States
• Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough, Maine, United States
• Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
• Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
• Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis, Missouri, United States
• Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
• UMDNJ University Hospital, Newark, New Jersey, United States
• Albert Einstein Cancer Center at Albert Einstein College of Medicine, The Bronx, New York, United States
• Blumenthal Cancer Center at Carolinas Medical Center, Charlotte, North Carolina, United States
• UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States
• Klinikum der J.W. Goethe Universitaet, Frankfurt, Germany

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07195734
  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGNANCT07264036
  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
  Vanessa Torrecillas
• RECRUITINGPHASE2NCT07121595
  Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
  University of Michigan Rogel Cancer Center
• RECRUITINGNCT05837221
  Microbiome in Head and Neck Squamous Cell Carcinoma
  University of Colorado, Denver
• RECRUITINGPHASE2NCT05576974
  A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
  University of Texas Southwestern Medical Center
• RECRUITINGPHASE1, PHASE2NCT06265025
  GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
  GeneMedicine Co., Ltd.
• RECRUITINGNANCT05811936
  The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
  Medical University of South Carolina
• ACTIVE NOT RECRUITINGPHASE1NCT05820711
  Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
  University of Wisconsin, Madison

See all trials for Squamous cell carcinoma of oral cavity and lip →